These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1011 related items for PubMed ID: 29915159

  • 1. Circulating Tumor Cells Undergoing EMT Provide a Metric for Diagnosis and Prognosis of Patients with Hepatocellular Carcinoma.
    Qi LN, Xiang BD, Wu FX, Ye JZ, Zhong JH, Wang YY, Chen YY, Chen ZS, Ma L, Chen J, Gong WF, Han ZG, Lu Y, Shang JJ, Li LQ.
    Cancer Res; 2018 Aug 15; 78(16):4731-4744. PubMed ID: 29915159
    [Abstract] [Full Text] [Related]

  • 2. Circulating tumor cells undergoing EMT are poorly correlated with clinical stages or predictive of recurrence in hepatocellular carcinoma.
    Chen Y, Li S, Li W, Yang R, Zhang X, Ye Y, Yu J, Ye L, Tang W.
    Sci Rep; 2019 May 08; 9(1):7084. PubMed ID: 31068623
    [Abstract] [Full Text] [Related]

  • 3. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
    Zhou Y, Wang B, Wu J, Zhang C, Zhou Y, Yang X, Zhou J, Guo W, Fan J.
    BMC Cancer; 2016 Jul 20; 16():506. PubMed ID: 27439521
    [Abstract] [Full Text] [Related]

  • 4. An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients.
    Liu YK, Hu BS, Li ZL, He X, Li Y, Lu LG.
    Hepatol Int; 2016 Jul 20; 10(4):640-6. PubMed ID: 27115761
    [Abstract] [Full Text] [Related]

  • 5. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
    Yao Z, Xiong Z, Li R, Liang H, Jia C, Deng M.
    Biomed Pharmacother; 2018 Aug 20; 104():102-109. PubMed ID: 29772429
    [Abstract] [Full Text] [Related]

  • 6. Circulating tumor cells in hepatocellular carcinoma: a pilot study of detection, enumeration, and next-generation sequencing in cases and controls.
    Kelley RK, Magbanua MJ, Butler TM, Collisson EA, Hwang J, Sidiropoulos N, Evason K, McWhirter RM, Hameed B, Wayne EM, Yao FY, Venook AP, Park JW.
    BMC Cancer; 2015 Mar 31; 15():206. PubMed ID: 25884197
    [Abstract] [Full Text] [Related]

  • 7. A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer.
    Nam SJ, Yeo HY, Chang HJ, Kim BH, Hong EK, Park JW.
    Cancer Res Treat; 2016 Oct 31; 48(4):1229-1242. PubMed ID: 27034142
    [Abstract] [Full Text] [Related]

  • 8. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF, Xu Y, Yang XR, Guo W, Zhang X, Qiu SJ, Shi RY, Hu B, Zhou J, Fan J.
    Hepatology; 2013 Apr 31; 57(4):1458-68. PubMed ID: 23175471
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, Wang R, Chen LB.
    Oncotarget; 2015 Jul 30; 6(21):18613-30. PubMed ID: 26164082
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Epithelial-mesenchymal transition phenotypes of circulating tumor cells correlate with the clinical stages and cancer metastasis in hepatocellular carcinoma patients.
    Chen J, Cao SW, Cai Z, Zheng L, Wang Q.
    Cancer Biomark; 2017 Dec 06; 20(4):487-498. PubMed ID: 28869439
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma.
    Schulze K, Gasch C, Staufer K, Nashan B, Lohse AW, Pantel K, Riethdorf S, Wege H.
    Int J Cancer; 2013 Nov 06; 133(9):2165-71. PubMed ID: 23616258
    [Abstract] [Full Text] [Related]

  • 15. Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Asano T, Yamada S, Fuchs BC, Takami H, Hayashi M, Sugimoto H, Fujii T, Tanabe KK, Kodera Y.
    Int J Oncol; 2017 May 06; 50(5):1647-1654. PubMed ID: 28350091
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Zhou W, Gong L, Wu Q, Xing C, Wei B, Chen T, Zhou Y, Yin S, Jiang B, Xie H, Zhou L, Zheng S.
    J Exp Clin Cancer Res; 2018 Sep 04; 37(1):215. PubMed ID: 30180906
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.